Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients | Scientific Reports
Soluble urokinase plasminogen activator receptor levels are predictive of COVID-19 severity in Afro-Caribbean patients | Biomarkers in Medicine
Blood test could offer life and death clues for African-American diabetics | American Heart Association
Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory fail
Diagnostics | Free Full-Text | Comparison of the Mortality Prediction Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in COVID-19 and Sepsis
IJERPH | Free Full-Text | Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Level as a Predictor of the Severity of Community-Acquired Pneumonia
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19 | Journal of the American Heart Association
Plasma levels of the active form of suPAR are associated with COVID-19 severity | Critical Care | Full Text
Signa Vitae-Journal of Anesthesiology, Intensive Care Journal, Emergency Medical Journal
Serum plasminogen activator urokinase receptor predicts elevated risk of acute respiratory distress syndrome in patients with sepsis and is positively associated with disease severity, inflammation and mortality
SuPAR, an emerging biomarker in kidney and inflammatory diseases | Postgraduate Medical Journal
Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia | European Respiratory Society
Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia | Critical Care | Full Text
Soluble urokinase plasminogen activator receptor level in individuals of advanced age | Scientific Reports
Il suPAR per la patologia renale come il colesterolo per quella cardiovascolare - Medical Systems SpA
suPARnostic Quick Triage Test Instruction Video - Welcome to the BioLogicTube
suPARcharging patient outcomes - suPARnostic® by ViroGates
J Clin Med Res
JCM | Free Full-Text | Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis
Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit | Scientific Reports
Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients | Critical Care | Full Text
suPARcharging patient outcomes - suPARnostic® by ViroGates
DSQUARED2 kid felpa gialla con stampa logo e cappuccio
Frontiers | Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19
Serum plasminogen activator urokinase receptor predicts elevated risk of acute respiratory distress syndrome in patients with sepsis and is positively associated with disease severity, inflammation and mortality
Mean suPAR (ng/ml) values in the various groups. | Download Table
NEJM: Discovery predicts future kidney disease with simple blood test
suPAR: A New Biomarker for Cardiovascular Disease? - ScienceDirect
suPAR elisa kit | Human suPAR (soluble urokinase-type plasminogen activator receptor) ELISA Kit-AAK31795.1
